OptionsHouse

Options Trading News

January 18, 2013  Fri 7:35 AM CT

MS: SEE CHART GET CHAIN FIND STRATEGIES

Profit Comes in Better Than Expected

Morgan Stanley reported fourth-quarter earnings of $0.28 a share, beating the $0.27 average analyst forecast. Revenue missed expectations, but investors are focusing on that profit number, sending MS up by more than 6 percent before the bell on my tradeMONSTER platform.

FDA Approves Migraine Skin Patch

NuPath announced late yesterday that the Food & Drug Administration approved its Zecuity skin patch for the treatment of migraines, making it the first such product on the market. PATH rallies 19 percent on the news.

Research in Motion Keeps Moving

Research in Motion keeps moving! Today, it was upgraded to "buy" from "hold" at Jefferies, which cited the possibility of its Blackberry mail being able to work on iPhones and Android devices. The target price was raised to $19.50 from $13. RIMM is up 7 percent in the premarket.

Capital One Drops on Earnings Miss

Capital One earned just $1.41 a share in the fourth quarter on revenue of $5.62 billion. Analysts had expected $1.58 and $5.71 billion, respectively. Those results have COF down 7 percent in early trading.

Share this article with your friends


OptionsHouse

Premium Services

Education & Strategy

The Movement of Delta

In our last column, we spoke about delta. You might remember that we discussed what delta was and what factors affected or changed delta. As you recall, we stated that three factors will have an effect on delta. They were movements of time, volatility, and underlying price. Today, we want to take a further look into the change of delta, this time focusing on change due to the movement in the underlying price. 

View more education articles »